PharmExec 50
Pharmaceutical Executive's annual PharmExec 50, on the cover of the April issue, tallies up the numbers underlying industry's 50 largest and most productive companies. In partnership with IMS Health, this year's PharmExec 50 moves beyond the raw data to deliver calculated analysis on the strategic ways forward for pharma. For an industry in transition, foresight is needed to unlock the future.

Will Narrowing Pharmacy Networks Squeeze Manufacturers?
Adam J. Fein, Ph.D, founder and president of Pembroke Consulting, Inc, details the shift in payers' preference toward narrow pharmacy networks. New pharmacy exclusions instigated by health plans limit patients' pharmacy options, and threaten access and brand position in the market. By anticipating the financial interests of payers, drug-makers can better prepare for and respond to the shifting pharmacy environment.